Expertise in
3
conditions

Dr. Robin Kroll

Obstetrics and Gynecology
3216 Ne 45th Pl, Suite 100, 
Seattle, WA 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
3
conditions
3216 Ne 45th Pl, Suite 100, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robin Kroll is an Obstetrics and Gynecologist in Seattle, Washington. Dr. Kroll is highly rated in 3 conditions, according to our data. Her top areas of expertise are Amenorrhea, Uterine Fibroids, Menopause, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion.

Her clinical research consists of co-authoring 20 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in WA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

3216 Ne 45th Pl, Suite 100, Seattle, WA 98105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase II Study of a Primary Dose of Investigational RSV Maternal Vaccine, Given Alone or With Boostrix, With a 2nd Dose Investigational RSV Maternal Vaccine
A Phase II Study of a Primary Dose of Investigational RSV Maternal Vaccine, Given Alone or With Boostrix, With a 2nd Dose Investigational RSV Maternal Vaccine
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Biological, Drug
Study Drugs: RSVPreF3, Boostrix-ex-US, Boostrix-US
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
A Phase III, Randomized, Multi-country Study to Evaluate the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response, Safety and Reactogenicity of RSV Maternal Vaccine When Co-administered With GSK's Quadrivalent Influenza D-QIV Vaccine in Healthy Non-pregnant Women 18-49 Years of Age.
A Phase III, Randomized, Multi-country Study to Evaluate the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response, Safety and Reactogenicity of RSV Maternal Vaccine When Co-administered With GSK's Quadrivalent Influenza D-QIV Vaccine in Healthy Non-pregnant Women 18-49 Years of Age.
Enrollment Status: Completed
Publish Date: October 05, 2023
Intervention Type: Combination product
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug
Study Phase: Phase 3
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

20 Total Publications

Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial.
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial.
Journal: American journal of obstetrics and gynecology
Published: October 27, 2023
Similar Doctors
Expertise in
13
conditions
Dr. Elizabeth M. Swisher
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
13
conditions
Dr. Elizabeth M. Swisher
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (3.0 miles away)
206-288-1000
Languages Spoken:
English, Castilian, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Elizabeth Swisher is a Gynecologic Oncologist and an Oncologist in Seattle, Washington. Dr. Swisher is highly rated in 13 conditions, according to our data. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Salpingo-Oophorectomy, and Oophorectomy. Dr. Swisher is currently accepting new patients.

Expertise in
12
conditions
Dr. Heidi J. Gray
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
12
conditions
Dr. Heidi J. Gray
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

The Association Of University Physicians

1959 Ne Pacific St, 
Seattle, WA 
 (1.1 miles away)
206-598-4333
Languages Spoken:
English, French, Malagasy, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Heidi Gray is a Gynecologic Oncologist and an Oncologist in Seattle, Washington. Dr. Gray is highly rated in 12 conditions, according to our data. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Oophorectomy. Dr. Gray is currently accepting new patients.

Expertise in
11
conditions
Dr. Barbara A. Goff
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
11
conditions
Dr. Barbara A. Goff
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

The Association Of University Physicians

1959 Ne Pacific St, 
Seattle, WA 
 (1.1 miles away)
206-598-4333
Languages Spoken:
English, Castilian, French, Japanese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Barbara Goff is a Gynecologic Oncologist and an Oncologist in Seattle, Washington. Dr. Goff is highly rated in 11 conditions, according to our data. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Salpingo-Oophorectomy, and Vulvectomy. Dr. Goff is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kroll's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile